Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,335,795
  • Shares Outstanding, K 47,588
  • Annual Sales, $ 399,250 K
  • Annual Income, $ -30,440 K
  • 60-Month Beta 1.43
  • Price/Sales 3.33
  • Price/Cash Flow N/A
  • Price/Book 2.97
Trade ATRC with:

Options Overview Details

View History
  • Implied Volatility 80.75% ( +3.17%)
  • Historical Volatility 41.30%
  • IV Percentile 76%
  • IV Rank 73.97%
  • IV High 106.87% on 07/26/24
  • IV Low 6.50% on 05/10/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 790
  • Open Int (30-Day) 754

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.19
  • Low Estimate -0.22
  • Prior Year -0.20
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.27 +20.28%
on 08/21/24
29.20 -4.14%
on 09/18/24
+4.12 (+17.26%)
since 08/16/24
3-Month
20.20 +38.56%
on 08/08/24
29.20 -4.14%
on 09/18/24
+6.79 (+32.03%)
since 06/18/24
52-Week
18.94 +47.78%
on 06/18/24
44.64 -37.30%
on 09/29/23
-15.47 (-35.60%)
since 09/18/23

Most Recent Stories

More News
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 27.99 (-0.29%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 27.99 (-0.29%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 27.99 (-0.29%)
AtriCure to Announce First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 27.99 (-0.29%)
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today...

ATRC : 27.99 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 30.53
2nd Resistance Point 29.86
1st Resistance Point 28.93
Last Price 27.99
1st Support Level 27.33
2nd Support Level 26.66
3rd Support Level 25.73

See More

52-Week High 44.64
Fibonacci 61.8% 34.82
Fibonacci 50% 31.79
Fibonacci 38.2% 28.76
Last Price 27.99
52-Week Low 18.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar